117 related articles for article (PubMed ID: 20920571)
1. The lipid peroxidation products as possible markers of Alzheimer's disease in blood.
Skoumalová A; Ivica J; Santorová P; Topinková E; Wilhelm J
Exp Gerontol; 2011 Jan; 46(1):38-42. PubMed ID: 20920571
[TBL] [Abstract][Full Text] [Related]
2. End products of lipid peroxidation in erythrocyte membranes in Alzheimer's disease.
Skoumalová A; Mádlová P; Topinková E
Cell Biochem Funct; 2012 Apr; 30(3):205-10. PubMed ID: 22161584
[TBL] [Abstract][Full Text] [Related]
3. Analysis of lipophilic fluorescent products in blood of Alzheimer's disease patients.
Chmátalová Z; Vyhnálek M; Laczó J; Hort J; Skoumalová A
J Cell Mol Med; 2016 Jul; 20(7):1367-72. PubMed ID: 26991927
[TBL] [Abstract][Full Text] [Related]
4. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer's disease: insights into the role of oxidative stress in Alzheimer's disease and initial investigations into a potential biomarker for this dementing disorder.
Sultana R; Mecocci P; Mangialasche F; Cecchetti R; Baglioni M; Butterfield DA
J Alzheimers Dis; 2011; 24(1):77-84. PubMed ID: 21383494
[TBL] [Abstract][Full Text] [Related]
5. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of lipofuscin-like pigments as an index of lead-induced oxidative damage in the brain.
Patková J; Vojtíšek M; Tůma J; Vožeh F; Knotková J; Santorová P; Wilhelm J
Exp Toxicol Pathol; 2012 Jan; 64(1-2):51-6. PubMed ID: 20598870
[TBL] [Abstract][Full Text] [Related]
7. The role of free radicals in canine counterpart of senile dementia of the Alzheimer type.
Skoumalova A; Rofina J; Schwippelova Z; Gruys E; Wilhelm J
Exp Gerontol; 2003 Jun; 38(6):711-9. PubMed ID: 12814808
[TBL] [Abstract][Full Text] [Related]
8. Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease.
Padurariu M; Ciobica A; Hritcu L; Stoica B; Bild W; Stefanescu C
Neurosci Lett; 2010 Jan; 469(1):6-10. PubMed ID: 19914330
[TBL] [Abstract][Full Text] [Related]
9. Glutamate uptake is decreased in platelets from Alzheimer's disease patients.
Ferrarese C; Begni B; Canevari C; Zoia C; Piolti R; Frigo M; Appollonio I; Frattola L
Ann Neurol; 2000 May; 47(5):641-3. PubMed ID: 10805335
[TBL] [Abstract][Full Text] [Related]
10. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
Singh M; Dang TN; Arseneault M; Ramassamy C
J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
[TBL] [Abstract][Full Text] [Related]
11. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
[TBL] [Abstract][Full Text] [Related]
13. Lipid peroxidation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.
Dei R; Takeda A; Niwa H; Li M; Nakagomi Y; Watanabe M; Inagaki T; Washimi Y; Yasuda Y; Horie K; Miyata T; Sobue G
Acta Neuropathol; 2002 Aug; 104(2):113-22. PubMed ID: 12111353
[TBL] [Abstract][Full Text] [Related]
14. Relation of plasma selenium and lipid peroxidation end products in patients with Alzheimer's disease.
Chmatalova Z; Vyhnalek M; Laczo J; Hort J; Pospisilova R; Pechova M; Skoumalova A
Physiol Res; 2017 Dec; 66(6):1049-1056. PubMed ID: 28937243
[TBL] [Abstract][Full Text] [Related]
15. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
[TBL] [Abstract][Full Text] [Related]
16. Lipid peroxidation in Alzheimer's disease: emphasis on metal-mediated neurotoxicity.
Obulesu M; Venu R; Somashekhar R
Acta Neurol Scand; 2011 Nov; 124(5):295-301. PubMed ID: 21303349
[TBL] [Abstract][Full Text] [Related]
17. Lipoproteins and lipid peroxidation in Alzheimer's disease.
Bassett CN; Montine TJ
J Nutr Health Aging; 2003; 7(1):24-9. PubMed ID: 12679837
[TBL] [Abstract][Full Text] [Related]
18. Enhanced ROS-generation in lymphocytes from Alzheimer's patients.
Leutner S; Schindowski K; Frölich L; Maurer K; Kratzsch T; Eckert A; Müller WE
Pharmacopsychiatry; 2005 Nov; 38(6):312-5. PubMed ID: 16342003
[TBL] [Abstract][Full Text] [Related]
19. A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease.
Greenberg N; Grassano A; Thambisetty M; Lovestone S; Legido-Quigley C
Electrophoresis; 2009 Apr; 30(7):1235-9. PubMed ID: 19288586
[TBL] [Abstract][Full Text] [Related]
20. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD
Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
